Hajjar R, Mariani JA, Pepe S, Chien KR, Power JM: Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in substantial animals. J Am Coll Cardiol 2007, 50(3):253?60. 20. Bridges CR: ‘Recirculating cardiac delivery’ method of gene delivery needs to be called ‘non-recirculating’ process. Gene Ther 2009, 16(7):939?40. Epub 2009 Apr two. 21. Grossman PM, Han Z, Palasis M, Barry JJ, Lederman RJ: Incomplete retention following direct myocardial injection. Cardiovasc Intervent 2002, 55(three):392?97. 22. Mingozzi F, Maus MV, Hui DJ, Sabatino DE, Murphy SL, Rasko JE, Ragni MV, Manno CS, Sommer J, Jiang H, Pierce GF, Ertl HC, Higher KA: CD8(+) T-cell responses to adeno-associated virus capsid in humans. Nat Med 2007, 13:419?22. 23. Gao G, Wang Q, Calcedo R, Mays L, Bell P, Wang L, Vandenberghe LH, Grant R, Sanmiguel J, Furth EE, Wilson JM: Adeno-associated virus-mediatedFargnoli et al. Journal of Translational Medicine 2014, 12:171 http://translational-medicine/content/12/1/Page 9 of24.25.26. 27.28.29.30.31.32.33.34.35.gene transfer to nonhuman primate liver can elicit destructive transgene-specific T cell responses. Hum Gene Ther 2009, 20(9):930?42. doi: 10.1089/hum.2009.060. Yockman JW, Kastenmeier A, Erickson HM, Brumbach JG, Whitten MG, Albanil A, Li DY, Kim SW, Bull DA: Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction. J Handle Release 2008, 132(three):260?66. Luo K, He B, Wu Y, Shen Y, Gu Z: Functional and biodegradable dendritic macromolecules with controlled architectures as nontoxic and effective nanoscale gene vectors. Biotechnol Adv 2014, 32(four):818?30. doi: ten.1016/j. biotechadv.2013.12.008. Epub 2014 Jan three. Makadia HK, Siegel SJ: Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. Polymers (Basel) 2011, three(three):1377?397. Mays LE, Wilson JM: The complex and evolving story of T cell activation to AAV vector-encoded transgene items.55685-58-0 manufacturer Mol Ther 2011, 19(1):16?7.Buy1809395-84-3 Epub 2010 Nov 30. Jooss K, Yang Y, Fisher KJ, Wilson JM: Transduction of dendritic cells byDNA viral vectors directs the immune response to transgene goods in muscle fibers.PMID:33499659 J Virol 1998, 72:4212?223. Zhang Y, Chirmule N, Gao G, Wilson J: CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: function of immature dendritic cells. J Virol 2000, 74:8003?010. Wang L, Dobrzynski E, Schlachterman A, Cao O, Herzog RW: Systemicprotein delivery by muscle-gene transfer is limited by a local immune response. Blood 2005, 105:4226?234. Yuasa K, Yoshimura M, Urasawa N, Ohshima S, Howell JM, Nakamura A, Hijikata T, Miyagoe-Suzuki Y, Takeda S: Injection of a recombinant AAV serotype two into canine skeletal muscle tissues evokes strong immune responses against transgene merchandise. Gene Ther 2007, 14(17):1249?260. Epub 2007 Jun 21. Snyder RO, Spratt SK, Lagarde C, Bohl D, Kaspar B, Sloan B, Cohen LK, Danos O: Effective and stable adeno-associated virus-mediated transduction inside the skeletal muscle of adult immunocompetent mice. Hum Gene Ther 1997, eight:1891?900. Wang L, Cao O, Swalm B, Dobrzynski E, Mingozzi F, Herzog RW: Major part of neighborhood immune responses in antibody formation to issue IX in AAV gene transfer. Gene Ther 2005, 12:1453?464. Cao O, Hoffman BE, Moghimi B, Nayak S, Cooper M, Zhou S, Ertl HC, Higher KA, Herzog RW: Effect with the underlying mutation as well as the route of vector administration on immune responses to factor IX in.